Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases

NCT01227954 is registered in ClinicalTrials.gov with Radiation Therapy Oncology Group as lead sponsor.

NCT NCT01227954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01227954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Hippocampal Avoidance During Whole Brain Radiotherapy for Brain Metastases
Lead sponsor
Radiation Therapy Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
December 31, 2016
Enrollment
113 (actual)
Sites
63

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive/functional effects, metastatic cancer, unspecified adult solid tumor, protocol specific